Fineline Cube

Follow:
14435 Articles
LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth
CompanyDeals

LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth

Innovent's Dabote Becomes First China-Originated KRAS G12C Inhibitor Approved in Macau
CompanyDrug

Innovent’s Dabote Becomes First China-Originated KRAS G12C Inhibitor Approved in Macau

NK CellTech Secures $14 Million in Series A+++ Financing to Advance NK Cell Therapies
CompanyDeals

NK CellTech Secures $14 Million in Series A+++ Financing to Advance NK Cell Therapies

Hengrui Pharmaceuticals Receives NMPA Clearance for SHR-2173 in Primary Membranous Nephropathy
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Clearance for SHR-2173 in Primary Membranous Nephropathy

J&J Submits sNDA to FDA for Caplyta to Prevent Schizophrenia Relapse
CompanyDrug

J&J Submits sNDA to FDA for Caplyta to Prevent Schizophrenia Relapse

Novartis' Coartem Baby Approved by Swissmedic for Newborns and Young Infants
CompanyDrug

Novartis’ Coartem Baby Approved by Swissmedic for Newborns and Young Infants

Jiangsu Hengrui Gains NMPA Clinical Clearance for HRS-9821 in COPD Treatment
CompanyDrug

Jiangsu Hengrui Gains NMPA Clinical Clearance for HRS-9821 in COPD Treatment

NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications
Policy / Regulatory

NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications

Boston Scientific's FARAPULSE Gains FDA Approval for Expanded Use in Persistent Atrial Fibrillation
CompanyMedical Device

Boston Scientific’s FARAPULSE Gains FDA Approval for Expanded Use in Persistent Atrial Fibrillation

HutchMed Announces First Commercial Shipments of Tazverik Across China
CompanyDrug

HutchMed Announces First Commercial Shipments of Tazverik Across China

Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion
CompanyDeals

Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion

RemeGen Submits New Indication Application for Disitamab Vedotin in Urothelial Carcinoma
CompanyDrug

RemeGen Submits New Indication Application for Disitamab Vedotin in Urothelial Carcinoma